Skip to content

The HIVE Community

The HIVE community supports Canadian dermatologists, allergists, immunologists and others with an interest in urticaria

Home
About HIVE
The Buzz
Contact

Protected: Dr. Anne Ellis reviews the Ligelizumab Phase 2b core study in CSU [Video 9 min]

December 10, 2020January 13, 2021 ~ hivecanada

This content is password protected. To view it please enter your password below:

Password:

Related

Post navigation

‹ PreviousDr. Sari Herman on “Fact or Fiction: Dispelling Misconceptions in CIU”, discusses the roles of different specialists in the optimal care of patients with chronic spontaneous urticaria [Video 6 min]

Next ›Dr. Vipul Jain reviews study “Ligelizumab achieves fast control of symptoms in more patients with chronic spontaneous urticaria versus omalizumab” as presented at the 2020 European Academy of Dermatology and Venereology Conference [Video 21 min]

Log in to the HIVE community on Sosido

Not a HIVE member?
Sign up here

The Health Innovation Virtual Engagement (HIVE) is a cross-specialty learning community for Canadian physicians, to support collaboration and enhance understanding of the condition of urticaria.

Some content on this site is password protected, available to HIVE members. You can find the password in your weekly Sosido HIVE email digest, sent every Wednesday.

Search for:

Website Powered by WordPress.com.